Hims Hers Health is trading 4.09% down at $30.45 as investors reassess payment and regulatory risks around its weight-loss subscriptions.
- Visa placed the company in its Acquirer Monitoring Program after elevated July card disputes, potentially creating nearly $75,000 in September surcharges.
- The FTC alleges deceptive billing, cancellation, and privacy practices.
- No separate August 26 announcement was identified; broader markets are essentially flat, making company-specific concerns the clearest pressure.